Table 1 Clinical information of patients
From: A proper protocol for routine 18F-FDG uEXPLORER total-body PET/CT scans
Characteristic | Full dose group (n = 10) | Half dose group (n = 10) | P |
|---|---|---|---|
Age (years) | 60.6 ± 10.8 (range 38–73) | 50.9 ± 10.9 (range 34–68) | 0.971 |
Sex | Â | Â | 0.264 |
Female | 1 | 3 | Â |
Male | 9 | 7 | Â |
Height (cm) | 171.6 ± 7.2 | 163.1 ± 6.2 | 0.015 |
Weight (kg) | 70.4 ± 11.8 | 59.9 ± 7.3 | 0.075 |
BMI (kg/m2) | 23.8 ± 2.5 | 22.5 ± 2.7 | 0.631 |
Blood glucose level before injection (mmol/L) | 5.7 ± 1.1 | 6.2 ± 1.0 | 0.123 |
Injected dose (MBq) | 259.1 ± 45.5 | 118.6 ± 16.5 | < 0.001 |
Histopathology | Â | Â | 0.329 |
Lung cancer | 8 | 10 | Â |
Oesophagus cancer | 1 | 0 | Â |
Colorectal cancer | 1 | 0 | Â |